Panel Discussion
Monday, September 22
05:45 PM - 06:30 PM
Live in Berlin
Less Details
This panel brings together experts to discuss the key challenges and opportunities when transitioning traditional pharmaceutical operations into the digital age. The focus will be on overcoming resistance, implementing new technologies, and ensuring long-term success. The following topics will be discussed in the panel:
As the Head CMC & Industrialization, PS Biotech & CGT unit at Bayer Pharmaceuticals, Dirk Böhm leads and coaches a cross-functional team responsible for process development, quality, manufacturing, and regulatory aspects of cell and gene therapy products. He has over 20 years of experience in international biotech and pharma manufacturing settings, with a strong track record of delivering excellent results efficiently and reliably to high quality standards.
His mission is to bring innovative therapies to patients through collaboration and excellence in execution across the Bayer CGT companies and the units in the Bayer group. He is passionate about building efficient teams and organizations, developing talent, and creating a motivating environment. He is also focused on continuous improvement and a clear strategy and direction to bring the best performance year over year. He is an innovation ambassador of the organization, supporting and enabling scouting of external technology and business opportunities.
I am an enthusiastic MES Business Solutions Manager with experience in delivering site wide digitalization projects ranging from environmental monitoring, MES and eLogs systems that interface with ERP’s LIMS, Data historians etc. My experience in the healthcare and pharmaceutical industry ranges from direct patient care, bioscience reagent manufacture, hospital diagnostics and human and animal pharmaceuticals. I have been an IBMS licensed biomedical scientist, worked in QC laboratories and now work to digitalize operations at the Lonza Netherlands Cell and Gene plant which currently includes allogeneic, autologous and mRNA modalities.
My main experience with MES systems lies with MODA ES, Lonza’s own next generation MES solution for eBR and eLogs. I lead an interdisciplinary team to bring this solution to the shop floor.
Outside of my core function I enjoy implementing systems to improve efficiency and drive operational improvements.
I am also an avid guitar player, having performed in numerous rock, blues and jazz bands as well as teaching guitar on an individual basis.